Colloidal Silver Secrets: TB

Showing posts with label TB. Show all posts

Tuesday, April 12, 2016

Tuberculosis Cases Increase: Colloidal Silver to the Rescue!

Click here to learn how to make colloidal silver...

Tuberculosis (TB) is a serious, infectious airborne bacterial disease caused by the bacterium Mycobacterium tuberculosis, which is largely spread by coughing.

Health authorities say up to one-third of the world’s population are infected with TB at any point in time with the vast majority of cases being spread throughout Africa and Asia.

TB was once the leading cause of death in the United States. Now, due to an unexpected increase in cases in the U.S., health authorities claim TB might be making a resurgence here.

Thankfully, clinical studies have shown antimicrobial silver to be highly effective against the TB pathogen. Here’s what you need to know…

Hi, Steve Barwick here, for The Silver Edge…

An article in the Washington Post dated March 24, 2016 says tuberculosis (TB) cases have increased in the U.S. for the first time in 23 years.

With a total of 9,563 cases being reported in the U.S. in 2015, which is 157 cases over those reported the previous year, the Post claims medical experts aren’t sure yet whether or not this increase could signal “a resurgence of one of the world’s deadliest diseases.”

The largest increases in cases of TB appear to be in California, Texas, Florida and New York – population centers constituting a whopping one-third of the U.S. population.

According to the Washington Post article:

“The disease is treatable with antibiotics, but the course can be long and complicated.

Certain forms of the bacterium that causes TB are becoming impervious to the drugs designed to kill them, leading to the development of multidrug-resistant strains of infection.

… In a related report, the CDC also called for increased awareness of the potential for active TB among foreign-born temporary workers.”

Will Colloidal Silver Help?

Does colloidal silver work against TB?

Some experts say it will. Indeed, in one clinical study researchers concluded that silver nanoparticles, “showed excellent antibacterial activities against M. tuberculosis around 10 ppm.”

The well-known and highly respected Dr. Gordon Pedersen wrote, in his 2014 book “A New Fighting Chance”:

“Tuberculosis is a common and often deadly infectious disease caused by mycobacteria…silver has destroyed tuberculosis in laboratory studies.

By drinking two teaspoons twice daily and inhaling from a nebulizer 30 minutes each day, you may affect the tuberculosis in both the lungs and the bloodstream.

Tuberculosis is not easy to beat. This dosage may need to be followed for weeks or months. You should see benefits after the first dose and each repeated use.”

According to a clinical study published in the Journal of Nanobiotechnology in May 2012, both gold and silver nanoparticles were demonstrated to be effective against the pathogen Bacillus Calmette-Guerin (BCG) which is used in clinical studies as a surrogate for the tuberculosis bacteria. The researchers wrote:

“Diseases such as tuberculosis (TB) have always had a large impact on human health. Bacillus Calmette-Guérin (BCG) is used as a surrogate for TB during the development of anti-TB drugs.

…The purpose of this study was to examine the potential of nanoparticles as anti-TB compounds by studying the interacting mechanisms between nanoparticles and bacteria.

… We investigated effects of gold and silver nanoparticles on BCG and Escherichia coli…The results suggest the nanoparticles have potential applications as anti-TB compounds… In terms of anti-TB drug development, this study suggests that nanoparticles may represent useful candidates for therapeutics.

Colloidal silver has been used as an antibacterial agent since ancient Greece. Unlike antibiotic drugs, bacteria cannot easily develop resistance because silver targets multiple components in the bacterial cell. As a result, silver is used in medical equipment coatings and dental resin components.

In conclusion, we have demonstrated that gold and silver nanoparticles display excellent antibacterial potential for the Gram negative bacteria E. coli and the Gram positive bacteria BCG [which serves as a surrogate for the tuberculosis pathogen].

…In terms of anti-TB drug development, this study suggests that NPs may represent useful candidates, but will require significant development to ensure optimal bactericidal activity and low host toxicity.”

-- Journal of Nanobiotechnology, May 2012, “Antibacterial Activities of Gold and Silver Nanoparticles Against Escherichia coli and bacillus Calmette-Guerin

Of related interest, a company called Klearsen Corporation apparently at one point developed an inhalable lung treatment utilizing atomized particles of ionic silver along with a small amount of peppermint oil.

The treatment was designed for tuberculosis, as well as for Mycopbacterium Avium Complex (MAC), i.e., the cause of so-called “hot tub lung,” in which the pathogens Mycobacterium avium or Mycobacterium abscessus infect the lungs similar to the way the tuberculosis pathogen does.

According to a Klearsen Corporation spokesman in March 2006, preliminary clinical studies had yielded some astonishing results:

"After having very good results against Mycobacterium tuberculosis, it seemed like the obvious step to screen the compound against M. avium and M. abscessus," said Steve Frank, the project director.

"We have been utilizing this compound in our patented Respiratory Inhalation Therapy treatment for years to deal with numerous ailments and this testing finally provides us with the substantiation necessary to move into the mycobacteria treatment arena."

Preliminary work with an MAC (Mycobacterium avium complex) patient in clinical trials has shown encouraging results and suggests that the treatment period for this condition could be reduced from a typical 12- to 16-month course of antibiotics to a 4-week course of the Klearsen Respiratory Inhalation Therapy.

‘This is a very exciting period of demonstration for our KC-287 antimicrobial compound,’ stated Chris Groutt, the Marketing Director. ‘We have all seen the dramatic capabilities of this product and now it is finally reaching the surface where it can benefit huge portions of the population.’

The treatment utilizes a nebulized mist of KC-287 to repeatedly coat the inner surfaces of the lungs. Being on the air-side of the tissue and formulated to gain enhanced entry into the bacterial cells allow the active agent to very effectively kill the mycobacteria with very low total dose to the subject.

Although the treatment is still in the experimental stage, early results are so encouraging, that clinical studies are moving forward.

Paul Whittle, the CEO of Klearsen Corp., is anxious to see this technology applied to MAC as well as tuberculosis patients:

‘Klearsen Corporation holds several patents relating to the respiratory therapy and the active agent. We are very pleased to see this level of performance in vivo.’”

While the above treatment was apparently patented by the Klearsen Corporation, and as of 2006 the company was “still seeking FDA approval.” That approval was apparently never granted, and the company website no longer exists.

Nevertheless, people from around the world are reporting good effects after using colloidal silver for TB. As an example, according to an online health board, colloidal silver is being used by individuals in Nigeria to help stem the country’s growing problem with tuberculosis. As one individual wrote:

“When we first started offering colloidal silver in 2007, we were approached by seven patients. Six were HIV positive and one had Tuberculosis. After three months of taking colloidal silver the lady with the TB was clean. Her doctor couldn’t believe it.”

Of course, anecdotal reports like that do not constitute “proof” that colloidal silver is effective against the TB pathogen. But you can learn more about silver’s ability to kill the TB pathogen by reading the following two articles and related clinical study:

Colloidal Silver and Tuberculosis

More Clinical Evidence Colloidal Silver Kills Tuberculosis Pathogen

Study: Silver Nanoparticles Effective Against Tuberculosis Bacteria

Learn More About Colloidal Silver…

If you’d like to learn more about colloidal silver and its remarkable ability to quite literally decimate infectious microorganisms – even drug-resistant pathogens – then consider taking a few moments to explore The Silver Edge website, which is the world’s largest online repository of factual information about colloidal silver.

For example:

If you’d like to learn more about the astonishing, infection-fighting qualities of colloidal silver, see over 100 articles at this link.

If you’d like to learn how hundreds of experienced colloidal silver users have cured their own infections and diseases with colloidal silver, see this link.

If you’d like to learn how incredibly easy it is to make your own high-quality colloidal silver for less than 36 cents a quart, and see how it compares to conventional colloidal silver generators, see this link.

If you’d like to learn why the Micro-Particle Colloidal Silver Generator is the world’s #1 best-selling colloidal silver generator, see this link.

Finally, if you’d like to save a whopping $100 on a brand new Micro-Particle Colloidal Silver Generator, so you can make your own high-quality colloidal silver for less than 36 cents a quart and avoid those high mark-ups in health food stores, see this link.

Meanwhile, I’ll be back next week with another great article on colloidal silver….

Yours for the safe, sane and responsible use of colloidal silver,

Steve Barwick, author
The Ultimate Colloidal Silver Manual

Helpful Links:

FREE Colloidal Silver Safe Dosage Report

Colloidal Silver Secrets Group on Facebook

Make Your Own Colloidal Silver for Pennies

.999 Pure Silver Wire for Making Colloidal Silver

Subscribe to the Colloidal Silver Secrets Ezine

Videos on Making and Using Colloidal Silver

Real-Life Colloidal Silver Success Stories

Colloidal Silver Update (News & Views)

The Ultimate Colloidal Silver Manual

The Colloidal Silver Secrets Video

Colloidal Silver Cures MRSA

Colloidal Silver Kills Viruses

Colloidal Silver Secrets blog

Meet Steve Barwick

Colloidal Silver

Important Note and Disclaimer: The contents of this Ezine have not been evaluated by the Food and Drug Administration. Information conveyed herein is from sources deemed to be accurate and reliable, but no guarantee can be made in regards to the accuracy and reliability thereof. The author, Steve Barwick, is a natural health journalist with over 30 years of experience writing professionally about natural health topics. He is not a doctor. Therefore, nothing stated in this Ezine should be construed as prescriptive in nature, nor is any part of this Ezine meant to be considered a substitute for professional medical advice. Nothing reported herein is intended to diagnose, treat, cure or prevent any disease. The author is simply reporting in journalistic fashion what he has learned during the past 17 years of journalistic research into colloidal silver and its usage. Therefore, the information and data presented should be considered for informational purposes only, and approached with caution. Readers should verify for themselves, and to their own satisfaction, from other knowledgeable sources such as their doctor, the accuracy and reliability of all reports, ideas, conclusions, comments and opinions stated herein. All important health care decisions should be made under the guidance and direction of a legitimate, knowledgeable and experienced health care professional. Readers are solely responsible for their choices. The author and publisher disclaim responsibility and/or liability for any loss or hardship that may be incurred as a result of the use or application of any information included in this Ezine.

Tuesday, April 14, 2015

Colloidal Silver and Tuberculosis

Learn more about the astonishing infection-fighting qualities of colloidal silver at www.TheSilverEdge.com

Tuberculosis, also called “TB” (short for tubercle bacillus), is a common and often deadly infectious disease caused by mycobacteria.

According to Wikipedia, “Tuberculosis typically attacks the lungs, but can also affect other parts of the body. It is spread through the air when people who have an active TB infection cough, sneeze, or otherwise transmit respiratory fluids through the air.”

TB is the second-most common cause of death from infectious disease worldwide, with HIV/AIDS being first. According to researchers, there are up to 13.7 million active cases of TB worldwide at any given time, resulting in 1.3 to 1.5 million deaths annually.

TB infections are extremely difficult to cure. Standard treatment for TB consists of the daily use of at least four different antibiotics for up to18 to 24 months.

Worse yet, cases of multiple-drug-resistant TB are now running rampant in some countries. And the mortality rates are skyrocketing.

Is colloidal silver effective against TB? Here’s what we know so far…

Hi, Steve Barwick here, for The Silver Edge…

In this clinical study, entitled “Nature-inspired Novel Drug Design Paradigm Using Nanosilver: Efficacy on Multi-drug-resistant Clinical Isolates of Tuberculosis,” researchers found that when testing a “novel form” of metallic nanosilver against antibiotic-resistant tuberculosis (TB), the pathogens were killed rapidly and successfully.

The researchers state that by capping (i.e, coating) metallic silver nanoparticles with bovine serum albumin and then testing it in the laboratory against sputum samples collected from pulmonary TB patients with multi-drug-resistant TB, they were able to demonstrate that this “novel nanosilver compound” constitutes a “potent anti-TB drug.”

The “Novel Drug” Ruse

While the study results are extremely encouraging, the idea that you need to "cap" (i.e., coat) metallic silver nanoparticles with a chemical substance in order to make them "less toxic" to the human body is ludicrous and counterproductive, as I’ll explain below.

In reality, the researchers coated the metallic silver nanoparticles with bovine serum albumin because they were attempting to come up with a "novel invention" so they could obtain FDA "drug" status for it, patent it, and monopolize its sale globally.

They as much as admitted so in the conclusion to their study, where they state, “Encouragingly, the results indicate that this novel design could be further extended for developing improved medicinal agents for combating multi-drug-resistant TB.” (See Current Microbiology, 2011, 62:715-726.)

There is really no other “benefit” to coating the metallic silver nanoparticles with bovine serum albumin.

You see, when metallic silver nanoparticles are coated with any substance, whether it’s bovine serum albumin, or milk protein, or PVP, or any other, the effectiveness of the silver against pathogens is dramatically limited.

That’s because coating the silver nanoparticles greatly diminishes their ability to release silver ions inside the human body.

And silver ions are what actually kill the pathogens, not the metallic silver nanoparticle being ingested (see “Experts: It’s the Silver Ion that Gives Colloidal Silver It’s Antimicrobial Power.”)

So for the coated metallic silver nanoparticles to release enough silver ions to be effective against pathogens, a person would have to ingest two or three times more nanosilver than they would if the silver nanoparticles had not been coated.

And that means the liver and the kidneys will have to deal with two or three times more silver “load” on the body than they otherwise would have. This is most definitely not prudent or wise.

A far safer and more effective way to go would have been to leave the silver nanoparticles uncoated, but use one-third to one-half the dose.

That far lower load of nanosilver on the body would give the researchers all of the safety and low toxicity they claim to have been looking for in the first place. And it would allow more than enough silver ions to be released from the uncoated silver nanoparticles to do the job against the pathogens.

The bottom line is this: The whole idea that capping the silver particles makes them "less toxic" to humans is ridiculous, because you're in essence forcing the infected individual to ingest two or three times more silver than necessary to kill the pathogens.

But using far smaller dosages of uncoated silver nanoparticles would allow the release of free silver ions (which kills the pathogens), while putting a mere one-third to one-half the silver load on the liver and kidneys.

Turning a Natural Substance Into a “Drug”

What's really happening here is that the medical researchers and the big drug companies want desperately to enter the market for silver-based infection-fighting substances.

After all, they know that silver is far more effective against infectious microorganism than their failing prescription antibiotic drugs.

The big drug companies also know they can't patent a completely natural substance like silver, so they have to come up with some way to create a "novel" silver-based product, or at the very least a "novel" delivery system.

I emphasize the word "novel" because that’s the single-most important criteria that must be passed for a product to receive a patent and to be sold as a drug.

In other words, for a medical product to be patented and sold as a drug, it must be unique and new, i.e., something that doesn't occur naturally and hasn't been manufactured the same way before.

As long as it's a "novel" (i.e., unique and new) substance or there's a novel methodology behind its creation, use, or delivery, Big Pharma can then patent it, turn it into a “drug,” and monopolize its sales worldwide making billions of dollars in the process.

Great News

In spite of my concerns about the use of coated silver nanoparticles in the above-described is study, the conclusions drawn by the study authors are nevertheless exciting and eye-opening, because it means silver has been clinically proven to destroy TB.

This once again confirms the incredible infection-fighting power of silver against infectious microbes – even drug-resistant microbes like the TB pathogen.

Think about it: Even silver nanoparticles coated with bovine serum albumin (which dramatically reduces their effectiveness) worked well against the drug-resistant TB pathogens in this study.

Can you imagine how well it might have worked if the silver nanoparticles were uncoated, or if pure ionic silver (i.e., typical health food store colloidal silver) had been used instead of some “novel” new invention?

So why not just tell people that small doses of safe, natural colloidal silver – consisting largely of pure silver ions which are the active, infection-fighting form of silver -- could just as effectively be used to kill the TB pathogen?

Well, there’s no money in that for the researchers, is there?

While silver ions are the active, infection-fighting specie of silver, they’re not patentable because anyone can produce them with a simple, home colloidal silver generator such as the new Micro-Particle Colloidal Silver Generator from The Silver Edge.

Look…millions of people worldwide have been ingesting tiny silver nanoparticles and pure silver ions in moderation for decades now, without undue harm or risk.

So the whole idea that tiny silver nanoparticles need to be coated in bovine serum albumin in order to “reduce toxicity” is nothing less than a spurious notion designed, in my opinion, to cover up the fact that the researchers were trying to create a “novel” drug for Big Pharma.

What’s more, it's important to note here that some people are quite allergic to bovine serum albumin, which is also known as BSA. Indeed, BSA is one of the allergens in the so-called "cow’s milk allergy."

Isn't it interesting that Big Pharma and their lackeys in the FDA create unwarranted fear over the use of safe, natural, colloidal silver, while simultaneously creating the illusion that their “novel” silver compound coated with bovine serum albumin is going to be "safe" and good for you?

As usual when dealing with the big drug companies and their researchers, rank deception and hypocrisy are the order of the day.

Can Colloidal Silver Cure TB?

While the study discussed above demonstrates that silver can indeed be used to kill the TB pathogen, it does not prove that silver is a “cure” for TB in the human body. More studies need to be done. But the current study is cause for much hope.

There are also some citations in very old medical literature (circa 1900) for the use of colloidal silver as a remedy for tuberculosis.

But you have to keep in mind that most of the formulations of colloidal silver used back then were often chemical in nature, which is to say, they were not electrically generated colloidal silver, but instead silver compounds made through a chemical process.

According to American Biotech Labs, a company which has paid for private studies to be conducted on colloidal silver in different areas of the world, colloidal silver has been used in Ghana, West Africa, to successfully treat such diseases as tuberculosis, malaria, gonorrhea, and more.

You might also find it worthwhile to do a Google search for US Patent #7,135,195. This patent claims that colloidal silver is very effective against the tuberculosis pathogen.

The patent claim, of course, only applies to the specific brand of colloidal silver discussed in the patent. And treating any serious disease, including TB, should be done only under the supervision of a licensed medical practitioner.

But the patent is one more link in the chain of evidence suggesting that colloidal silver could be highly effective against the tuberculosis pathogen in the human body, just as it is against so many other pathogens.

According to the “Purpose” and “Conclusions” sections of the patent dealing with their study on colloidal silver and the tuberculosis bacteria (section 9, “Evidence of Efficacy of 10 ppm Silver Against Tuberculosis Bacteria”), colloidal silver at only 10 ppm has been demonstrated to effectively kill the TB bacteria:

Purposes

“The purpose of this example is to demonstrate the efficacy of a silver composition of the present invention against the bacteria that cause tuberculosis.

This example describes the procedures for evaluation of the present invention for tuberculocidal efficacy.

The methodology is based on the Tuberculocidal Activity Test Method as accepted by the EPA on Dec. 11, 1985. [Refer to United States Environmental Protection Agency, 1986. Office of Pesticides and Toxic Substances. Data Call-In Notice for Tubercuolocidal Effectiveness Data for All Antimicrobial Pesticides with Tuberculocidal Claims. (Received Jun. 13, 1986).

Conclusions

The use of silver compositions of the present invention is effective against tuberculosis bacteria.

A method comprising the step of administering silver compositions of the present invention is effective against tuberculosis organisms.”

So it's fascinating that only 10 ppm colloidal silver was shown to be effective against the tuberculosis pathogen in the study cited in the above-mentioned patent.

However, it’s important to note that this claim is based on a test-tube study used in the patenting of a colloidal silver-based product. It was not a human study. So we still await further clinical studies before drawing any hard-and-fast conclusions.

But as biologist James South, MA, once wrote in the International Anti-Aging Bulletin:

"From 1900 to the beginning of the modern antibiotic era - circa 1940 with the introduction of sulfa drugs - Silver was one of the mainstays of medical practice in Europe and America.

Various forms of Silver were used to treat literally hundreds of ailments: lung infections such as pneumonia, tuberculosis and pleurisy; sexual diseases such as gonorrhea and syphillis; plus…

…skin conditions such as cuts, wounds, leg ulcers, pustular eczema, impetigo and boils; acute meningitis and epidemic cerebro-spinal meningitis; infectious diseases such as Mediterranean fever, erysipelas…

…cystitis, typhus, typhoid fever, and tonsilitis; eye disorders such as dacryocystitis, corneal ulcers, conjunctivitis and blepharitis; and various forms of septicemia, including puerperal fever, peritonitis and post-abortion septicemia."

And as Dr. Kent Holtorf, M.D., of the Holtorf Medical Group has stated:

"Silver formulations have also been used in hundreds of various infections and other conditions including pneumonia, tuberculosis, eczema, meningitis, erysipelas, Mediterranean fever, corneal ulcers, conjunctivitis and septicemia."

In 1910, Dr Henry Crooks a pioneer in colloidal chemistry wrote that:

"...certain metals such as silver, when in a colloidal state, have a highly germicidal action but are quite harmless to human beings…

...Bronchial tuberculosis…Staphylococcus pyogenes, various Streptococci and other pathogenic organisms are all killed in three to four minutes:

in fact no microbe is known that is not killed by this colloid in laboratory experiments in six minutes, [and] the concentration of the [silver] does not exceed twenty-five parts per million…"

And as Alfred B. Searle wrote in 1921, his book, Use of Colloids in Health & Disease:

“...it is now definitely known that the germicidal properties of certain colloidal metals are based chiefly on the fact that the metals are in the colloidal state…

...a vigorous growth of b. tuberculosis was killed by colloidal silver in four minutes (a solution of 1 part silver to 2,000 parts fluid)."

Finally, the well-known and highly respected Dr. Gordon Pedersen wrote, in his 2014 book “A New Fighting Chance”:

“Tuberculosis is a common and often deadly infectious disease caused by mycobacteria.

…silver has destroyed tuberculosis in laboratory studies.

So perhaps if clinical researchers were more interested in curing disease than in making money for their pharmaceutical company masters, we'd know by now whether or not colloidal silver -- without any of the bells-and-whistles to make it a "novel drug" -- would indeed work against Tuberculosis, now that the dread disease is becoming endemic once again worldwide.

Real-Life Accounts?

Are there any real-life accounts of colloidal silver being used to cure a case of tuberculosis?

Unfortunately, I haven’t been able to find any. That’s likely because most cases of TB are in Third World countries where colloidal silver is not available. But I have seen a few anecdotal accounts that clearly point in that direction.

For example, here’s an anecdotal account I found on the CureZone.com website, about a woman who’d tested positive for latent TB for 32 years, but who no longer tested positive after only two months of daily use of colloidal silver:

“A close family member had been ‘infected’ with tuberculosis 32 years ago.

When doctors did the TB test, she would always test positive. Just recently she has a physical done because she just got hired by a medical institution.

They tested her for TB and found she was not infected and quite normal.

Just two months of colloidal silver took care of 32 years of a stubborn bacteria that would not go away.”

Of course, that testimonial account still doesn’t prove colloidal silver would cure an active TB infection. After all, you can test “positive” for years after an initial TB infection, even if you’re no longer battling the actual infection. The immune system simply keeps the pathogen in a more-or-less dormant state.

But the testimonial above does indeed indicate that colloidal silver can rid the body of the pathogen, even after it’s been established there for decades.

You can learn more about the astonishing effectiveness of colloidal silver against today’s growing scourge of drug-resistant pathogens at at this link.

In the Meantime

In the meantime, take a look at these real-life colloidal silver success stories, and discover how thousands of people worldwide are curing their own infections with safe, natural colloidal silver.

Or if you’d like to learn more about making your own high-quality colloidal silver for just pennies…